QC
GMAB icon

Quadrature Capital’s Genmab GMAB Stock Holding History

Quadrature Capital’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Buy
78,569
+45,170
+135% +$1.2M 0.02% 481
2026
Q1 		$896K Sell
33,399
-46,452
-58% -$1.39M 0.01% 595
2025
Q4 		$2.46M Buy
79,851
+44,349
+125% +$1.38M 0.03% 327
2025
Q3 		$1.09M Buy
+35,502
New +$865K 0.01% 373
2025
Q2 		– Sell
-22,169
Closed -$434K – 1209
2025
Q1 		$434K Buy
+22,169
New +$465K 0.01% 618

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quadrature Capital's GMAB Position: Q2 2026 in Review

Quadrature Capital increased its Genmab (GMAB) stake by 135% in Q2 2026, buying an estimated $1.2M and bringing the position to 78,569 shares worth $2.16M. The position accounts for 0.02% of the portfolio, ranked #481.

Quadrature Capital first reported a position in GMAB in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.46M in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Quadrature Capital held 78,569 shares of Genmab worth $2.16M as of Q2 2026.
  • Quadrature Capital bought 45,170 Genmab shares in Q2 2026, an estimated $1.2M.
  • Genmab made up 0.02% of Quadrature Capital's portfolio in Q2 2026, its #481 holding.
  • Quadrature Capital first reported a position in Genmab in Q1 2025 and has held it in 5 quarters since.
  • Quadrature Capital's Genmab position peaked at $2.46M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.